Home/Zena Therapeutics/Eileen Carry, Ph.D.

EC

Eileen Carry, Ph.D.

Co-Founder & Chief Scientific Officer

Zena Therapeutics

Therapeutic Areas

Mental Health Addiction Disorders Neurological Disorders

Zena Therapeutics Pipeline

Drug	Indication	Phase
GABA-A PAM Anxiolytic	Anxiety Disorders (General, Panic, Social) & Withdrawal-Induced Anxiety (Opioid/Alcohol Use Disorder)	Preclinical

Leadership Team at Zena Therapeutics

Ariane Vasilatis, Ph.D.

Co-Founder & Chief Executive Officer

View full Zena Therapeutics profile